Brian N. Kelly, PhD, DABCC, FAACC

Currently, I am pursuing opportunities to assist small clinical laboratories in the implementation of liquid-chromatography mass-spectrometry based analysis.  I am working with physician owned laboratories, as well as a nascent reference laboratory as this field develops.  Combining my education, board-certification, expertise in analytical methods alongside regulatory knowledge, I am uniquely positioned to improve patient care via laboratory medicine.  Previously, I was the Partnership for Clean Competition Research Fellow at the Sports Medicine Research and Testing Laboratory in Salt Lake City, Utah.  There, I developed mass-spectrometry based detection methods for various substances that are prohibited by the World Anti-Doping Agency.  In the recent past, I have completed the Clinical Chemistry and Laboratory Medicine Fellowship at the University of Virginia and have achieved board certification in Clinical Chemistry.  During the three years at the University of Virginia, I was developing novel, quantitative, circulating ribonucleic-acid based assays to detect administration of recombinant human growth hormone.  I have been fortunate to have been awarded the Paul E. Strandjord Young Investigator Award by the Academy of Clinical Laboratory Physicians and Scientists two times, and have been invited to present my research results domestically and overseas, and have published numerous articles in peer-reviewed journals.  In total, I have over 11 years of post-graduate research experience ranging from X-ray crystallography to molecular biology to interfering substances in point-of-care glucose meters.  I graduated with a double major in Biochemistry and Molecular, Cellular, and Developmental Biology from the University of Colorado and completed my PhD in Biochemistry from the University of Utah.